Health condition
Lipodystrophy syndromes
Lipodystrophies are rare disorders of fat tissue - absent or misdistributed body fat with severe metabolic consequences: extreme insulin resistance, diabetes, very high triglycerides and fatty liver, often in strikingly lean-looking people.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Patterns range from generalised (near-total fat absence) to partial - classically fat loss from limbs and buttocks with facial and neck sparing (familial partial lipodystrophy)
-
The metabolic signature: severe insulin resistance, early diabetes, triglycerides high enough to cause pancreatitis, PCOS-like features and fatty liver
-
Leptin deficiency drives relentless hunger in generalised forms
-
Suspect it when 'type 2 diabetes' occurs in a slim, muscular-looking person with very high insulin requirements and triglycerides
-
Specialist treatments include metreleptin (leptin replacement) for generalised forms, alongside aggressive conventional metabolic care
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
Fat is an organ, and when it is missing the energy it should store invades liver, muscle and pancreas instead. People with partial lipodystrophy often look athletic - lean, veined limbs - while carrying the metabolic profile of severe obesity: insulin needs in the hundreds of units, triglycerides in the tens, recurrent pancreatitis and advancing fatty liver disease. Women are more visibly and metabolically affected in familial partial forms (most often LMNA gene variants), and the diagnosis hides in plain sight inside diabetes clinics.
Diagnosis and treatment routes
Recognition starts with looking: fat distribution examination, skinfold assessment, leptin levels and genetic panels confirm it, and family screening follows. Management is intensive - diet remarkably low in fat, insulin sensitisers, modern lipid drugs - while metreleptin transforms generalised disease and is available via specialist centres; national lipodystrophy services exist and referral there is worthwhile. If your diabetes behaves nothing like your body shape suggests it should, seek an endocrine opinion - privately, typically within about two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant endocrinologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Lipodystrophy syndromes.
Quick, plain-English answers to what people ask us most.
-
What are lipodystrophy syndromes?
Lipodystrophy syndromes are a group of rare conditions characterised by abnormal loss or redistribution of fat tissue in the body, which can be inherited or acquired, and often lead to metabolic problems including insulin resistance and diabetes. They range from affecting small areas to the entire body.
-
What causes lipodystrophy syndromes?
Inherited forms result from specific genetic mutations affecting fat cell development or function, while acquired forms can be triggered by autoimmune disease, certain medications (including some HIV treatments), or, rarely, follow significant illness. Identifying the underlying cause helps guide management.
-
What are the symptoms of lipodystrophy?
Symptoms include noticeable loss of fat from specific or widespread areas of the body, alongside metabolic complications such as insulin resistance, high triglycerides, and fatty liver disease. The specific pattern and severity vary depending on the type of lipodystrophy.
-
Is lipodystrophy dangerous?
Yes, the associated metabolic complications, particularly severe insulin resistance and diabetes, can be serious and need active management to prevent long-term complications like heart disease. Regular monitoring and treatment of these metabolic issues is central to care.
-
Is lipodystrophy genetic?
Some forms are inherited, caused by specific gene mutations affecting fat tissue, while others are acquired due to autoimmune disease or medication effects rather than being directly inherited. Genetic testing can clarify which type you have if an inherited form is suspected.
-
Can lipodystrophy be cured?
There's no cure for the underlying fat tissue abnormality, but the associated metabolic complications can be actively managed with medication, diet and, in some specific severe genetic forms, specialised hormone replacement treatment (metreleptin). Management focuses on controlling these complications long-term.
-
How is lipodystrophy treated?
Treatment focuses on managing metabolic complications such as diabetes and high triglycerides through diet, medication, and in specific severe cases, leptin replacement therapy. Regular monitoring for complications affecting the liver, heart and kidneys is also important.
-
How does lipodystrophy affect diabetes and metabolic health?
Because fat tissue plays an important role in storing excess energy safely, its loss or dysfunction leads fat to be deposited elsewhere, particularly the liver and muscles, causing significant insulin resistance and often severe diabetes that can be more difficult to control than typical type 2 diabetes. Specialist endocrinology input is usually needed for optimal management.
-
Generalised vs partial lipodystrophy — what's the difference?
Generalised lipodystrophy involves widespread loss of fat tissue across the body and tends to cause more severe metabolic complications, while partial lipodystrophy affects specific body regions, sparing others, and can have a more variable metabolic impact. The specific pattern helps guide diagnosis of the underlying type and cause.
-
When should I see a specialist about lipodystrophy, and how quickly can I be seen privately?
Unusual fat loss or redistribution, especially alongside difficult-to-control diabetes, should prompt endocrinology referral. Private endocrinology consultations can typically be arranged within about two weeks, considerably faster than standard NHS waiting times.